Impact of response to electrical cardioversion before catheter ablation for persistent atrial fibrillation: a

Márton Boga1, Zoltán Salló1, Gábor Orbán1

  • 1Heart and Vascular Center, Semmelweis University, Városmajor Street 68, Budapest 1122, Hungary.

PubMed

Insights

Maintaining sinus rhythm after electrical cardioversion in persistent atrial fibrillation (AF) patients predicts better outcomes following catheter ablation. Patients who maintained sinus rhythm (SR) showed higher freedom from atrial tachyarrhythmia post-ablation.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Persistent atrial fibrillation (AF) poses a significant challenge in cardiovascular medicine.
  • Anti-arrhythmic drugs (AADs) and electrical cardioversion (ECV) are common strategies to restore sinus rhythm (SR).
  • Predicting outcomes after catheter ablation in AF patients remains crucial for treatment planning.

Purpose of the Study:

  • To investigate whether maintaining sinus rhythm (SR) after pre-procedural electrical cardioversion (ECV) predicts outcomes in persistent atrial fibrillation (AF) patients undergoing catheter ablation.
  • To compare the efficacy of catheter ablation in patients with sustained SR post-ECV versus those with AF recurrence before ablation.

Main Methods:

  • A cohort of 219 persistent AF patients on AADs undergoing ECV 1-6 months prior to ablation was analyzed.
  • Patients were grouped into ECV-SR (maintained SR) and ECV-AF (AF recurrence) based on pre-ablation rhythm.
  • Propensity score matching created comparable groups (94 patients each) for outcome analysis.
  • Follow-up was conducted for a median of 42 months, assessing freedom from atrial tachyarrhythmia and AF recurrence.

Main Results:

  • Freedom from atrial tachyarrhythmia at 36 months was significantly higher in the ECV-SR group (51.2%) compared to the ECV-AF group (31.4%).
  • Recurrence patterns differed, with persistent AF more common in the ECV-AF group and paroxysmal AF in the ECV-SR group.
  • Freedom from persistent AF at 36 months was also significantly better in the ECV-SR group (84.3%) versus the ECV-AF group (54%).
  • These findings remained consistent across multi-variable adjustments and subgroups, including pulmonary vein isolation (PVI)-only procedures.

Conclusions:

  • Maintaining SR after pre-procedural ECV is a strong predictor of successful catheter ablation outcomes in persistent AF patients.
  • A positive response to ECV may identify patients suitable for a pulmonary vein isolation (PVI)-only ablation strategy.
  • These results highlight the prognostic value of pre-ablation rhythm status for guiding AF management.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
168
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
72
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
80
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
110
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
167